A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s disease

INTRODUCTION: Because of its genetic underpinnings and consistent age of onset within families, autosomal dominant Alzheimer’s disease (ADAD) provides a unique opportunity to conduct clinical trials of investigational agents as preventative or symptom-delaying treatments. The design of such trials m...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Alzheimers Res Ther
Päätekijät: Grill, Joshua D., Bateman, Randall J., Buckles, Virginia, Oliver, Angela, Morris, John C., Masters, Colin L., Klunk, William E., Ringman, John M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511231/
https://ncbi.nlm.nih.gov/pubmed/26203303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-015-0135-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia